Robin Croce v. HHS - Tdap, Guillain-Barre Syndrome (2020)

Robin Croce filed a petition for compensation under the National Vaccine Injury Compensation Program on September 1, 2017. She alleged that she developed Guillain-Barre Syndrome (GBS) after receiving a tetanus-diphtheria-acellular pertussis (Tdap) vaccination on June 24, 2016.

The respondent denied that the vaccination caused her injury. The parties reached a joint stipulation to settle the case, which was filed on February 6, 2020.

Special Master Mindy Michaels Roth adopted the stipulation. The settlement included a lump sum of $2,324.50, payable jointly to Ms.

Croce and Pendrick Capital Partners II LLC, for a balance due for past medical expenses, with Ms. Croce agreeing to endorse the check to Pendrick Capital Partners II LLC.

Additionally, a lump sum of $10,135.15 was awarded, payable jointly to Ms. Croce and Westside Regional Medical Center, for a balance due for past medical expenses, with Ms.

Croce agreeing to endorse this check to Westside Regional Medical Center. Ms.

Croce was also awarded a lump sum of $147,500.00, payable to her, representing compensation for all other damages. The total compensation awarded was $160,000.

The decision was issued on February 6, 2020. The public decision does not describe the onset of symptoms, specific clinical details of the GBS, any diagnostic tests performed, or treatments received.

The specific mechanism of causation was not detailed in the public decision. Petitioner was represented by Alison Haskins, Esq., of Maglio Christopher and Toale, PA, and respondent was represented by Adriana Teitel, Esq., of the US Department of Justice.